Symbols / ACON
ACON Chart
About
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 2.66M |
| Enterprise Value | -9.69M | Income | -7.39M | Sales | 67.48K |
| Book/sh | 21.46 | Cash/sh | 16.95 | Dividend Yield | — |
| Payout | 0.00% | Employees | 5 | IPO | — |
| P/E | — | Forward P/E | -0.18 | PEG | — |
| P/S | 39.37 | P/B | 0.12 | P/C | — |
| EV/EBITDA | 1.46 | EV/Sales | -143.57 | Quick Ratio | 16.31 |
| Current Ratio | 17.01 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -2258.79 | EPS next Y | -13.71 | EPS Growth | — |
| Revenue Growth | 31.50% | Earnings | 2025-11-12 06:00 | ROA | -52.37% |
| ROE | -97.72% | ROIC | — | Gross Margin | -7.83% |
| Oper. Margin | -96.66% | Profit Margin | 0.00% | Shs Outstand | 1.05M |
| Shs Float | 671.34K | Short Float | 16.90% | Short Ratio | 0.08 |
| Short Interest | — | 52W High | 229.50 | 52W Low | 2.34 |
| Beta | 1.44 | Avg Volume | 887.40K | Volume | 42.86K |
| Target Price | $23.00 | Recom | None | Prev Close | $2.51 |
| Price | $2.52 | Change | 0.40% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$23.00
Mean price target
2. Current target
$2.52
Latest analyst target
3. DCF / Fair value
$-70.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.52
Low
$23.00
High
$23.00
Mean
$23.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-20 | main | Ascendiant Capital | Buy → Buy | $23 |
| 2025-09-19 | main | Ascendiant Capital | Buy → Buy | $22 |
| 2024-12-13 | down | Maxim Group | Buy → Hold | — |
| 2024-11-27 | main | Ascendiant Capital | Buy → Buy | $1 |
| 2024-08-26 | main | Ascendiant Capital | Buy → Buy | $2 |
| 2024-07-29 | init | Ascendiant Capital | — → Buy | $2 |
- Debt-free Aclarion now holds $21.6M to grow its AI back pain tool - Stock Titan ue, 13 Jan 2026 08
- Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication | ACON Stock News - Quiver Quantitative hu, 04 Dec 2025 08
- ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Stocktwits hu, 08 Jan 2026 08
- Is Aclarion Stock Built to Withstand a Pullback? - Trefis Sat, 20 Dec 2025 08
- Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq Sat, 06 Dec 2025 08
- Aclarion stock soars after participation in international pain meeting - Investing.com Mon, 13 Oct 2025 07
- ACON Stock: Analyst Boosts Price Target While Maintaining Buy Ra - GuruFocus Fri, 19 Sep 2025 07
- Why Is Aclarion Stock (ACON) Up Today? - TipRanks hu, 08 Jan 2026 08
- $ACON stock is up 38% today. Here's what we see in our data. - Quiver Quantitative hu, 08 Jan 2026 08
- Aclarion (Nasdaq: ACON) hires Jason Brosniak to expand Nociscan adoption in Eastern U.S. - Stock Titan ue, 02 Dec 2025 08
- 266M with low back pain — Aclarion Nociscan MR spectroscopy + AI identifies painful discs at ISPN - Stock Titan Mon, 13 Oct 2025 07
- Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative hu, 05 Feb 2026 08
- Aclarion Stock Climbs 50% After Strong 2025 Results And 2026 Outlook - Nasdaq hu, 08 Jan 2026 08
- Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan hu, 04 Dec 2025 08
- Aclarion, Inc. Secures $10.4 Million in Common-Stock Financing to Strengthen Balance Sheet and Extend Operating Runway - Quiver Quantitative ue, 13 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 10 | 62 | — | Purchase at price 6.20 per share. | NESS BRENT | Chief Executive Officer | — | 2025-11-26 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.32M | -4.71M | -5.42M | -4.66M |
| TotalUnusualItems | -944.73K | 573.60K | -1.19K | 377.20K |
| TotalUnusualItemsExcludingGoodwill | -944.73K | 573.60K | -1.19K | 377.20K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -6.99M | -4.91M | -7.07M | -4.95M |
| ReconciledDepreciation | 193.14K | 162.67K | 143.62K | 186.39K |
| ReconciledCostOfRevenue | 84.66K | 75.73K | 65.30K | 69.17K |
| EBITDA | -6.26M | -4.14M | -5.42M | -4.29M |
| EBIT | -6.46M | -4.30M | -5.56M | -4.47M |
| NetInterestIncome | -535.15K | -608.12K | -1.51M | -476.48K |
| InterestExpense | 535.47K | 608.29K | 1.51M | 476.48K |
| InterestIncome | 318.00 | 172.00 | 2.51K | |
| NormalizedIncome | -6.05M | -5.48M | -7.07M | -5.33M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.99M | -4.91M | -7.07M | -4.95M |
| TotalExpenses | 5.56M | 4.95M | 5.62M | 3.01M |
| TotalOperatingIncomeAsReported | -5.51M | -4.88M | -5.56M | -2.95M |
| DilutedAverageShares | 1.04K | 91.00 | 54.00 | 49.00 |
| BasicAverageShares | 1.04K | 91.00 | 54.00 | 49.00 |
| DilutedEPS | -6.77K | -53.97K | -138.59K | -121.55K |
| BasicEPS | -6.77K | -53.97K | -138.59K | -121.55K |
| DilutedNIAvailtoComStockholders | -7.05M | -4.91M | -7.48M | -5.96M |
| NetIncomeCommonStockholders | -7.05M | -4.91M | -7.48M | -5.96M |
| PreferredStockDividends | 59.67K | 415.52K | 1.01M | |
| NetIncome | -6.99M | -4.91M | -7.07M | -4.95M |
| NetIncomeIncludingNoncontrollingInterests | -6.99M | -4.91M | -7.07M | -4.95M |
| NetIncomeContinuousOperations | -6.99M | -4.91M | -7.07M | -4.95M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -6.99M | -4.91M | -7.07M | -4.95M |
| OtherIncomeExpense | -944.73K | 573.87K | -1.19K | -1.52M |
| OtherNonOperatingIncomeExpenses | -212.45K | 265.00 | -1.90M | |
| SpecialIncomeCharges | -1.28M | 0.00 | 0.00 | 378.51K |
| OtherSpecialCharges | 1.28M | -378.51K | ||
| GainOnSaleOfSecurity | 334.98K | 573.60K | -1.19K | -1.31K |
| NetNonOperatingInterestIncomeExpense | -535.15K | -608.12K | -1.51M | -476.48K |
| InterestExpenseNonOperating | 535.47K | 608.29K | 1.51M | 476.48K |
| InterestIncomeNonOperating | 318.00 | 172.00 | 2.51K | |
| OperatingIncome | -5.51M | -4.88M | -5.56M | -2.95M |
| OperatingExpense | 5.47M | 4.88M | 5.56M | 2.94M |
| OtherTaxes | 0.00 | 1.14K | 800.00 | 800.00 |
| ResearchAndDevelopment | 888.77K | 873.34K | 1.07M | 787.85K |
| SellingGeneralAndAdministration | 4.59M | 4.00M | 4.49M | 2.16M |
| SellingAndMarketingExpense | 976.55K | 757.00K | 498.00K | 330.81K |
| GeneralAndAdministrativeExpense | 3.61M | 3.25M | 3.99M | 1.83M |
| OtherGandA | 3.61M | 3.25M | 3.99M | 1.83M |
| GrossProfit | -38.93K | -324.00 | -4.85K | -8.88K |
| CostOfRevenue | 84.66K | 75.73K | 65.30K | 69.17K |
| TotalRevenue | 45.72K | 75.40K | 60.44K | 60.29K |
| OperatingRevenue | 45.72K | 75.40K | 60.44K | 60.29K |
| Line Item | 2023-12-31 | 2022-12-31 | ||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | 0.00 | ||
| OrdinarySharesNumber | 1.37K | 91.00 | 54.00 | 49.00 |
| ShareIssued | 1.37K | 91.00 | 54.00 | 49.00 |
| NetDebt | 104.66K | 1.57M | ||
| TotalDebt | 1.13M | 2.00M | ||
| TangibleBookValue | -323.65K | -1.90M | 1.02M | -6.87M |
| InvestedCapital | 970.06K | 397.73K | 2.23M | -3.73M |
| WorkingCapital | -329.15K | -1.90M | 1.01M | -6.89M |
| NetTangibleAssets | -323.65K | -1.90M | 1.02M | -6.87M |
| CommonStockEquity | 970.06K | -728.00K | 2.23M | -5.73M |
| PreferredStockEquity | 245.00 | |||
| TotalCapitalization | 970.06K | -728.00K | 2.23M | -5.73M |
| TotalEquityGrossMinorityInterest | 970.06K | -728.00K | 2.23M | -5.73M |
| StockholdersEquity | 970.06K | -728.00K | 2.23M | -5.73M |
| RetainedEarnings | -51.26M | -44.28M | -39.37M | -31.89M |
| AdditionalPaidInCapital | 52.23M | 43.55M | 41.60M | 26.16M |
| CapitalStock | 0.00 | 0.00 | 5.00 | 254.00 |
| CommonStock | 0.00 | 0.00 | 5.00 | 9.00 |
| PreferredStock | 0.00 | 0.00 | 245.00 | |
| TotalLiabilitiesNetMinorityInterest | 1.15M | 3.19M | 688.67K | 7.62M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 0.00 | 0.00 |
| PreferredSecuritiesOutsideStockEquity | 7.10M | |||
| CurrentLiabilities | 1.15M | 3.19M | 688.67K | 7.62M |
| OtherCurrentLiabilities | 92.64K | 443.79K | 345.24K | |
| CurrentDebtAndCapitalLeaseObligation | 1.13M | 2.00M | ||
| CurrentDebt | 1.13M | 2.00M | ||
| LineOfCredit | 0.00 | |||
| CurrentNotesPayable | 0.00 | 1.13M | 0.00 | 2.00M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 450.48K | 355.08K | 165.95K | |
| PayablesAndAccruedExpenses | 610.31K | 1.26M | 522.72K | 5.62M |
| CurrentAccruedExpenses | 78.70K | 502.64K | 60.52K | 696.58K |
| InterestPayable | 0.00 | 98.69K | 0.00 | 356.22K |
| Payables | 531.60K | 760.53K | 462.20K | 4.92M |
| OtherPayable | 6.02K | 1.71K | 4.64K | 5.76K |
| DividendsPayable | 0.00 | 3.86M | ||
| AccountsPayable | 525.58K | 758.82K | 457.56K | 1.06M |
| TotalAssets | 2.12M | 2.46M | 2.91M | 1.89M |
| TotalNonCurrentAssets | 1.30M | 1.17M | 1.21M | 1.16M |
| GoodwillAndOtherIntangibleAssets | 1.29M | 1.17M | 1.21M | 1.14M |
| OtherIntangibleAssets | 1.29M | 1.17M | 1.21M | 1.14M |
| NetPPE | 5.50K | 1.78K | 3.35K | 12.64K |
| AccumulatedDepreciation | -54.80K | -53.40K | -70.03K | -100.59K |
| GrossPPE | 60.30K | 55.18K | 73.37K | 113.23K |
| OtherProperties | 18.19K | 18.19K | ||
| MachineryFurnitureEquipment | 60.30K | 55.18K | 55.18K | 95.04K |
| CurrentAssets | 824.28K | 1.29M | 1.70M | 732.20K |
| OtherCurrentAssets | 4.17K | 41.63K | 49.56K | 273.39K |
| CurrentDeferredAssets | 119.73K | 100.59K | 0.00 | 0.00 |
| RestrictedCash | 10.00K | 10.00K | 10.00K | 20.00K |
| PrepaidAssets | 218.40K | 102.65K | 150.05K | 273.39K |
| Receivables | 18.33K | 13.42K | 18.65K | 6.28K |
| OtherReceivables | 154.00 | 84.00 | ||
| AccountsReceivable | 18.33K | 13.27K | 18.57K | 6.28K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | 0.00 | 0.00 |
| GrossAccountsReceivable | 18.33K | 13.27K | 18.57K | 6.28K |
| CashCashEquivalentsAndShortTermInvestments | 453.66K | 1.02M | 1.47M | 432.53K |
| CashAndCashEquivalents | 453.66K | 1.02M | 1.47M | 432.53K |
| CashFinancial | 1.02M | 1.47M | 432.53K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.59M | -3.77M | -5.16M | -2.50M |
| RepurchaseOfCapitalStock | 0.00 | -1.00K | 0.00 | |
| RepaymentOfDebt | -300.97K | 0.00 | -2.00M | 0.00 |
| IssuanceOfDebt | 0.00 | 2.25M | 0.00 | 2.94M |
| IssuanceOfCapitalStock | 6.57M | 1.46M | 8.55M | 0.00 |
| CapitalExpenditure | -321.94K | -119.52K | -208.87K | -102.00K |
| InterestPaidSupplementalData | 13.07K | 10.71K | ||
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | ||
| EndCashPosition | 463.66K | 1.03M | 1.48M | 452.53K |
| BeginningCashPosition | 1.03M | 1.48M | 452.53K | 14.98K |
| ChangesInCash | -567.41K | -451.74K | 1.03M | 437.55K |
| FinancingCashFlow | 5.03M | 3.31M | 6.19M | 2.94M |
| CashFlowFromContinuingFinancingActivities | 5.03M | 3.31M | 6.19M | 2.94M |
| NetOtherFinancingCharges | -1.25M | -398.22K | -365.06K | |
| ProceedsFromStockOptionExercised | 0.00 | 8.55M | ||
| NetPreferredStockIssuance | 1.00M | 0.00 | 0.00 | |
| PreferredStockPayments | 0.00 | -1.00K | 0.00 | |
| PreferredStockIssuance | 1.00M | 1.00K | 0.00 | |
| NetCommonStockIssuance | 5.57M | 1.46M | 8.55M | 0.00 |
| CommonStockIssuance | 5.57M | 1.46M | 8.55M | 0.00 |
| NetIssuancePaymentsOfDebt | -300.97K | 2.25M | -2.00M | 2.94M |
| NetShortTermDebtIssuance | 2.25M | 0.00 | 2.94M | |
| ShortTermDebtPayments | 0.00 | -2.00M | ||
| ShortTermDebtIssuance | 2.25M | 0.00 | 2.94M | |
| NetLongTermDebtIssuance | -300.97K | 2.25M | -2.00M | 0.00 |
| LongTermDebtPayments | -300.97K | 0.00 | -2.00M | 0.00 |
| LongTermDebtIssuance | 0.00 | 2.25M | 0.00 | 2.00M |
| InvestingCashFlow | -321.94K | -119.52K | -207.87K | -102.00K |
| CashFlowFromContinuingInvestingActivities | -321.94K | -119.52K | -207.87K | -102.00K |
| NetOtherInvestingChanges | 1.00K | |||
| NetIntangiblesPurchaseAndSale | -316.82K | -119.52K | -208.87K | -102.00K |
| PurchaseOfIntangibles | -119.52K | -208.87K | -102.00K | |
| NetPPEPurchaseAndSale | -5.12K | 0.00 | 1.00K | 0.00 |
| SaleOfPPE | 0.00 | 1.00K | 0.00 | |
| PurchaseOfPPE | 0.00 | |||
| OperatingCashFlow | -5.27M | -3.65M | -4.95M | -2.40M |
| CashFlowFromContinuingOperatingActivities | -5.27M | -3.65M | -4.95M | -2.40M |
| ChangeInWorkingCapital | -564.24K | 622.87K | -616.10K | 629.27K |
| ChangeInPayablesAndAccruedExpense | -283.85K | 662.90K | -516.28K | 823.82K |
| ChangeInAccruedExpense | -127.45K | 442.27K | 86.82K | 624.21K |
| ChangeInInterestPayable | 0.00 | -6.19K | 200.71K | 114.40K |
| ChangeInPayable | -156.40K | 220.63K | -603.10K | 199.60K |
| ChangeInAccountPayable | -156.40K | 220.63K | -603.10K | 199.60K |
| ChangeInPrepaidAssets | -287.66K | -38.54K | -87.52K | -210.76K |
| ChangeInReceivables | 7.27K | -1.49K | -12.29K | 16.22K |
| ChangesInAccountReceivables | 7.27K | -1.49K | -12.29K | 16.22K |
| OtherNonCashItems | 2.03M | 596.34K | 1.30M | 1.90M |
| StockBasedCompensation | 287.45K | 456.00K | 1.29M | 177.49K |
| DepreciationAmortizationDepletion | 193.14K | 162.67K | 143.62K | 186.39K |
| DepreciationAndAmortization | 193.14K | 162.67K | 143.62K | 186.39K |
| AmortizationCashFlow | 191.74K | 161.11K | 139.12K | |
| AmortizationOfIntangibles | 191.74K | 161.11K | 139.12K | |
| Depreciation | 1.40K | 1.56K | 4.50K | |
| OperatingGainsLosses | -223.10K | -573.46K | 3.79K | -343.12K |
| GainLossOnInvestmentSecurities | -335.03K | -573.46K | 30.39K | |
| GainLossOnSaleOfPPE | 0.00 | 3.79K | 0.00 | |
| NetIncomeFromContinuingOperations | -6.99M | -4.91M | -7.07M | -4.95M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ACON
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|